Pediatric expert consensus on the application of intravenous immunoglobulin in children with hematological/neoplastic diseases.
- Collective Name:Pediatric Branch of Guangdong Medical Association;Editorial Department of Chinese Journal of Contemporary Pediatrics
- Publication Type:Journal Article
- MeSH: Child; China; Consensus; Hematologic Neoplasms/drug therapy*; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous/therapeutic use*
- From: Chinese Journal of Contemporary Pediatrics 2021;23(4):319-327
- CountryChina
- Language:Chinese
- Abstract: Intravenous immunoglobulin (IVIG) has been widely used in chemotherapy for hematological malignancies, targeted therapy, and hematopoietic stem cell transplantation; however, there are still no available guidelines or consensus statements on the application of IVIG in pediatric hematological/neoplastic diseases at present in China and overseas. This consensus is developed based on the research advances in the application of IVIG in pediatric hematological/neoplastic diseases across the world and provides detailed recommendations for the clinical application of IVIG in pediatric hematological/neoplastic diseases and the prevention and treatment of related adverse reactions.